Trees outside woodlands in England mapped for first time
Top tree scientists at the UK's Forest Research agency built a comprehensive picture of single trees in urban and rural areas in a map that goes live on Saturday.
The tool will allow conservation groups and local authorities to target tree planting efforts more accurately by pinpointing lone trees that could be connected to nearby wooded areas, bolstering habitats for wildlife, they said.
The Environment Department (Defra) said this will help to support of the Government's pledge to expand nature-rich habitats and help to achieve its legally-binding target to increase England's woodland canopy to 16.5% of total land area by 2050.
Forestry Minister Mary Creagh said: 'Our precious street trees improve air quality, mark the changing seasons and provide us with peace, shade and joy. Their value simply cannot be overstated.
'This groundbreaking new tree census will not only help us better understand our current tree canopy cover, but allow us to identify areas where we can create more nature rich habitats for wildlife and people to enjoy as part of our Plan for Change.'
Sir William Worsley, chairman of the Forestry Commission, said: 'This has been a real endeavour by the team – the results are spectacular and will be invaluable to us as we strive to meet our legal target to increase tree planting cover.
'The map fills critical data gaps about our national tree assets, helping us understand this natural resource and the benefits it brings, including carbon storage. Many people – from citizens to governments – will use the map to make evidence-based decisions to improve management and protection of our trees.'
Freddie Hunter, head of remote sensing at Forest Research, said: 'This is an exciting moment. By using the latest technology, we have been able to pinpoint all tree cover across England, including trees outside of woodland for the first time.
'This laser technology measures the Earth's surface using satellite imagery, which we can use to capture tree canopy cover form a comprehensive picture across the breadth of the country and will be vital in informing future tree-planting'.
The maps now shows that these single trees make up 30% of England's tree cover.
They can play an important role in storing carbon, regulating temperatures, and mitigating against climate change impacts, such as flooding and over-heating in towns and cities, Defra said.
The trees can also help to improve health and wellbeing in urban areas by boosting nature and reducing the impacts of air pollution.
The map, which is fully automated and can be updated regularly to capture changes in tree canopy cover, was funded by Defra's Natural Capital and Ecosystem Assessment (NCEA) programme.
It comes as part of wider Government efforts to boost woodlands, including recent announcements of a new national forest, increasing timber in construction to boost forestry and sustainable house building and the establishment of a dedicated tree-planting taskforce.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
3 hours ago
- Washington Post
RFK Jr. announces end to some mRNA contracts, including for flu, covid
Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday a crackdown on mRNA vaccine technology and research to develop it, following months of pressure from anti-vaccine activists. According to HHS, the Trump administration has launched 'a coordinated wind-down' of 22 mRNA projects supported by the Biomedical Advanced Research and Development Authority, the government's biodefense agency. Other mRNA projects funded by HHS are not affected by the new announcement.


Fox News
6 hours ago
- Fox News
RFK Jr cancels $500 million in mRNA research, HHS to prioritize 'safer' vaccine alternatives
A total of 22 mRNA vaccine development contracts totaling roughly $500 million have been canceled, the Department of Health and Human Services (HHS) announced Tuesday. The mRNA investments were part of the government's Biomedical Advanced Research and Development Authority (BARDA), a division of HHS that drives some of the country's most advanced scientific research, such as the development of vaccines, drugs and other tools to fight national health threats. The termination of the 22 BARDA contracts follows a several-weeks-long internal review to determine a path forward when it comes to these investments. "We reviewed the science, listened to the experts, and acted," HHS Secretary Robert F. Kennedy Jr. said Tuesday. "BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." In a short video explaining the move, Kennedy said the benefits simply do not outweigh the risks associated with mRNA vaccines. Kennedy went on to point out that not only do mRNA vaccines – as shown during the COVID-19 pandemic – not perform well against viruses that infect the upper respiratory tract, but they also do not defend against mutations of the viruses they are intended to go after. "This dynamic drives a phenomena called anogenic shift, meaning that the vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine," Kennedy said in the video. For example, the HHS Secretary pointed to the Omicron variant of the COVID-19 virus, which infected many millions, including those who had been vaccinated against COVID. "A single mutation can make mRNA vaccines ineffective," Kebbedy added, noting that the same risks also apply to the flu virus. The move to cancel the mRNA contracts under BARDA, will not entirely cancel all mRNA vaccine research done by the government, a source familiar with the move indicated. In addition to allowing some final-stage contracts to run their course to completion in an effort to preserve prior taxpayer investments, ongoing mRNA research at the National Institutes of Health (NIH) will not be impacted by this latest move. Meanwhile, in lieu of the terminated mRNA research and investments at BARDA, HHS will focus on "safer, broader vaccine strategies," Kennedy indicated. "To replace the troubled mRNA programs, we're prioritizing the development of safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate," Kennedy said in his video explanation about the terminated mRNA investments. During the video, Kennedy reiterated his support for "safe, effective vaccines" for any American who wants them. "That's why we're moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions."

Wall Street Journal
10 hours ago
- Wall Street Journal
NASA and Congress Wrestle Over the Space Station—and How to Replace It
The fight over government spending is reaching 250 miles above the Earth's surface. The International Space Station for more than two decades has been the centerpiece of human spaceflight at the National Aeronautics and Space Administration. Government leaders are now jousting over funding for the ISS, while NASA is signaling it will start pulling back on some station activities ahead of its planned decommissioning in 2030, when private space stations are envisioned taking its place.